Document is current

Article History

Received: 7 May 2023

Accepted: 7 February 2024

First Online: 27 March 2024

Declarations

:

: Not applicable.

: Not applicable.

: Laurent Peyrin-Biroulet reports personal fees from AbbVie, Allergan, Alma, Amgen, Applied Molecular Transport, Arena, Biogen, BMS, Boehringer Ingelheim, Celgene, Celltrion, Enterome, Enthera, Ferring, Fresenius Kabi, Galapagos, Genentech, Gilead, Hikma, InDex Pharmaceuticals, Inotrem, Janssen, Lilly, MSD, Mylan, Nestle, Norgine, OSE Immunotherapeutics, Oppilan Pharma, Pfizer, Pharmacosmos, Roche, Samsung Bioepis, Sandoz, Sterna, Sublimity Therapeutics, Takeda, Theravance, Tillots, and Vifor. Perttu Arkkila has been an advisory board member of Janssen. Alessandro Armuzzi reports grants from Biogen, MSD, Pfizer, and Takeda; and personal fees from AbbVie, Allergan, Amgen, Arena, Biogen, Bristol Myers Squibb, Celltrion, Eli Lilly, Ferring, Galapagos, Gilead, Janssen, MSD, Mylan, Novartis, Pfizer, Protagonist Therapeutics, Roche, Samsung Bioepis, Sandoz, Takeda, and TiGenix. Silvio Danese reports personal fees from AbbVie, Allergan, Amgen, AstraZeneca, Athos Therapeutics, Biogen, Boehringer Ingelheim, Celgene, Celltrion, Eli Lilly, Enthera, Ferring Pharmaceuticals Inc., Gilead, Hospira, Inotrem, Janssen, Johnson & Johnson, MSD, Mundipharma, Mylan, Pfizer, Roche, Sandoz, Sublimity Therapeutics, Takeda, TiGenix, UCB Inc., and Vifor. Marc Ferrante reports grants from Janssen, Pfizer, Takeda, and Viatris; personal fees from AbbVie, Boehringer Ingelheim, Celgene, Eli Lilly, Falk, Janssen, Lamepro, Medtronic, Regeneron, Samsung Bioepis, Sandoz, Thermo Fisher, Truvion Healthcare, and Viatris. Jordi Guardiola reports personal fees from AbbVie, Chiesi, Ferring, GE Healthcare, Janssen, Kern Pharma, MSD, Pfizer, Roche, and Takeda. Jørgen Jahnsen reports personal fees from AbbVie, Astro Pharma, Boehringer Ingelheim, BMS, Celltrion, Ferring, Gilead, Hikma, Janssen, Meda, MSD, NappPharma, Novartis, Orion Pharma, Pfizer, Pharmacosmos, Roche, Sandoz, Takeda, Tillotts, and Unimedic Pharma. Edouard Louis has received research grants from Janssen, Pfizer, and Takeda; received educational grants from AbbVie, Janssen, and Takeda; received speaker fees from AbbVie, Celgene, Falk, Ferring, Janssen, MSD, Pfizer, and Takeda; been an advisory board member for AbbVie, Arena, Eli Lilly, Celgene, Ferring, Galapagos, Gilead, Janssen, MSD, Pfizer, and Takeda; and been a consultant of AbbVie. Milan Lukáš has received financial support for research and educational activities from Janssen, Pfizer, and Takeda; and has been an advisory board member for Egis, Janssen, and Takeda. Walter Reinisch reports grants from Abbott Laboratories, AbbVie, Aesca, Centocor, Falk, Immundiagnostik, Janssen, MSD, Sandoz, and Takeda. Xavier Roblin reports personal fees from Amgen, Celltrion, Gilead, Janssen, MSD, Pfizer, Takeda, and Tillots; personal fees from Abbott Laboratories, AbbVie, Aesca, Algernon, Amgen, AM Pharma, AMT, AOP Orphan, Aptalis, Arena Pharmaceuticals, Astellas, AstraZeneca, Avaxia, Bioclinica, Biogen IDEC, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Cellerix, Celltrion, Centocor, Chemocentryx, Covance, Danone Austria, DSM, Elan, Eli Lilly, Ernst & Young, Elan, Falk, Ferring, Galapagos, Gatehouse Bio Inc., Genentech, Gilead, Grünenthal, ICON, Immundiagnostik, InDex Pharmaceuticals, Inova, Intrinsic Imaging, J&J, Janssen, Kyowa Hakko Kirin Pharma, Lipid Therapeutics, LivaNova, Mallinckrodt, Medahead, MedImmune, Millenium, Mitsubishi Tanabe Pharma Corporation, MSD, Nash Pharmaceuticals, Nestle, Nippon Kayaku, Novartis, Ocera, OMass, Otsuka, Parexel, PDL, Periconsulting, Pfizer, Pharmacosmos, Philip Morris Institute, PLS Education, Procter & Gamble, Prometheus, Protagonist, Provention, Quell Therapeutics, Robarts Clinical Trial, Roland Berger GmBH, Sandoz, Schering-Plough, Second Genome, Seres Therapeutics, Setpointmedical, Shire, Sigmoid, Sublimity, Takeda, Therakos, Theravance, TiGenix, UCB, Vifor, Yakult, Zeeland, Zyngenia, and 4SC. Philip J Smith reports personal fees from AbbVie, Celltrion, Dr Falk, Galapagos, Janssen, Takeda, and Tillotts Pharma. Taek Kwon, Jeeyoung Kim, Dong-Hyeon Kim, and Sangwook Yoon are employees of Celltrion. Raja Atreya reports grants and personal fees from AbbVie, Amgen, Arena Pharmaceuticals, Biogen, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Celltrion, Falk Foundation, Ferring, Fresenius Kabi, Galapagos, Gilead, GlaxoSmithKline, InDex Pharmaceuticals, Janssen-Cilag, Kliniksa Pharmaceuticals, Lilly, Merck Sharp & Dohme, Novartis, Pandion, Pfizer, Roche Pharma, Samsung Bioepis, Takeda Pharma, and Viatris.